Dataset Information

Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries.

ABSTRACT:

Background

Considering the recently growing number of potentially traumatic events in Europe, the European Psychiatric Association undertook a study to investigate clinicians' treatment choices for post-traumatic stress disorder (PTSD).

Methods

The case-based analysis included 611 participants, who correctly classified the vignette as a case of PTSD, from Central/ Eastern Europe (CEE) (n = 279), Southern Europe (SE) (n = 92), Northern Europe (NE) (n = 92), and Western Europe (WE) (N = 148).

Results

About 82% woulduse antidepressants (sertraline being the most preferred one). Benzodiazepines and antipsychotics were significantly more frequently recommended by participants from CEE (33 and 4%, respectively), compared to participants from NE (11 and 0%) and SE (9% and 3%). About 52% of clinicians recommended trauma-focused cognitive behavior therapy and 35% psychoeducation, irrespective of their origin. In the latent class analysis, we identified four distinct "profiles" of clinicians. In Class 1 (N = 367), psychiatrists would less often recommend any antidepressants. In Class 2 (N = 51), clinicians would recommend trazodone and prolonged exposure therapy. In Class 3 (N = 65), they propose mirtazapine and eye movement desensitization reprocessing therapy. In Class 4 (N = 128), clinicians propose different types of medications and cognitive processing therapy. About 50.1% of participants in each region stated they do not adhere to recognized treatment guidelines.

Conclusions

Clinicians' decisions for PTSD are broadly similar among European psychiatrists, but regional differences suggest the need for more dialogue and education to harmonize practice across Europe and promote the use of guidelines.

SUBMITTER: Rojnic Kuzman M

PROVIDER: S-EPMC10988156 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries.

Rojnic Kuzman Martina M Padberg Frank F Amann Benedikt L BL Schouler-Ocak Meryam M Bajic Zarko Z Melartin Tarja T James Adrian A Beezhold Julian J Artigue Gómez Jordi J Arango Celso C Jendricko Tihana T Ismayilov Jamila J Flannery William W Chumakov Egor E Başar Koray K Vahip Simavi S Dudek Dominika D Samochowiec Jerzy J Mihajlovic Goran G Rota Fulvia F Stoppe Gabriela G Dom Geert G Catthoor Kirsten K Chkonia Eka E Heitor Dos Santos Maria João MJ Telles Diogo D Falkai Peter P Courtet Philippe P Patarák Michal M Izakova Lubomira L Skugarevski Oleg O Barjaktarov Stojan S Babic Dragan D Racetovic Goran G Fiorillo Andrea A Carpiniello Bernardo B Taube Maris M Melamed Yuval Y Chihai Jana J Cozman Doina Constanta Maria DCM Mohr Pavel P Szekeres György G Delic Mirjana M Mazaliauskienė Ramunė R Tomcuk Aleksandar A Maruta Nataliya N Gorwood Philip P

European psychiatry : the journal of the Association of European Psychiatrists 20240307 1

<h4>Background</h4>Considering the recently growing number of potentially traumatic events in Europe, the European Psychiatric Association undertook a study to investigate clinicians' treatment choices for post-traumatic stress disorder (PTSD).<h4>Methods</h4>The case-based analysis included 611 participants, who correctly classified the vignette as a case of PTSD, from Central/ Eastern Europe (CEE) (<i>n</i> = 279), Southern Europe (SE) (<i>n</i> = 92), Northern Europe (NE) (<i>n</i> = 92), and ...[more]

PMID: 38450651

Similar Datasets

Project description:BackgroundKidney transplantation (KT) is a life-saving therapy for kidney failure. However, KT recipients can suffer from debilitating depression, post-traumatic stress disorder (PTSD), and suicide. In contrast to PTSD, post-traumatic growth (PTG) is a positive psychologic change in response to a challenging situation. PTG has been studied in other chronic diseases, but less is known about its role in the setting of KT. We sought to elucidate the prevalence, predictors, and the effect of PTSD and PTG on post-KT outcomes. We also considered the roles of benefit finding and resilience.MethodsIn a literature review, we identified publications that examined PTSD, PTG, benefit finding, and/or resilience in KT recipients. We excluded case reports and first-person narratives. Publications meeting the specified criteria after full text review underwent data abstraction and descriptive analysis.ResultsOf the 1013 unique citations identified, 39 publications met our criteria. PTSD was the most common construct evaluated (16 publications). Resilience was studied in 11 publications, PTG in nine, and benefit finding in five. Up to 21% of adult and 42% of pediatric KT recipients may experience PTSD, which is associated with lower quality of life (QOL), impaired sleep, and other psychiatric comorbidity. PTG was associated with improved QOL, kidney function, and reduced risk of organ rejection. Although benefit finding tended to increase post KT, resilience remained stable post KT. Like PTG, resilience was associated with lower psychologic distress and increased treatment adherence and confidence in the health care team.ConclusionsPTG, resilience, and benefit finding appear to reduce the risk of PTSD, promote well-being, and reduce risk of graft failure in KT recipients. Future research to understand these relationships better will allow clinicians and researchers to develop interventions to promote PTG, resilience, and benefit finding, and potentially improve post-transplant outcomes such as adherence and reducing risk of organ rejection.

Dataset Information

Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries.

Background

Methods

Results

Conclusions

Publications

Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets